Cyclin D2 and Gastric Cancer
Author Information
Author(s): Yu J, Leung W K, Ebert M P A, Leong R W L, Tse P C H, Chan M W Y, Bai A H C, To K F, Malfertheiner P, Sung J J Y
Primary Institution: The Chinese University of Hong Kong
Hypothesis
The study aims to examine the methylation status of the CpG sites in the cyclin D2 promoter region of gastric cancer and correlate it with cyclin D2 expression.
Conclusion
Promoter hypermethylation of cyclin D2 is associated with loss of cyclin D2 expression in gastric cancer.
Supporting Evidence
- Hypermethylation at the CpG-rich region was detected in gastric cancer cell lines without cyclin D2 expression.
- 65.2% of gastric cancers with cyclin D2 methylation had no cyclin D2 mRNA expression.
- Only 12.5% of methylation-negative cases lost cyclin D2 mRNA expression.
Takeaway
This study found that when a certain gene (cyclin D2) is turned off in stomach cancer cells due to a chemical change (methylation), it can lead to cancer growth.
Methodology
The study used methylation-specific PCR and bisulphite DNA sequencing to analyze the methylation status of the cyclin D2 promoter in gastric cancer tissues and cell lines.
Limitations
The study does not explore other potential mechanisms for cyclin D2 loss in gastric cancer beyond methylation.
Participant Demographics
30 males and 17 females with a mean age of 64.8 years.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website